Partners Carl Hittinger and Marc Schildkraut and Counsel Tyson Herrold recently authored an article titled "Hospital Mergers: The Future of COPA Immunity," for The Temple 10-Q, the business law magazine published by Temple University Beasley School of Law.
Published Aug. 9, the article examines the implications of the Federal Trade Commission’s opposition to a Certificate of Public Advantage (COPA) for the merger of State University of New York Upstate Medical University and Crouse Health System, Inc. COPAs provide some exemptions to antitrust laws – for example, when a state determines that a merger would be in the interest of greater access to and/or quality of healthcare services.